Companies · Other Technology
HERZLIYA · Other Technology
Diligence memoA one-page analyst read on APOS - Medical & Sports Technologies Ltd. — recommendation, valuation, rhythm, risks.→APOS - Medical & Sports Technologies Ltd. looks under-valued against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the technology sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
APOS - Medical & Sports Technologies Ltd. is one of 21302 Other Technology companies tracked from HERZLIYA. By capital raised it ranks in the upper tier (ahead of 85% of sector peers), and mid-pack by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 25%.
Round size and date are reported; the stage label is inferred from round size (latest is Series B — a $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the technology sector profile. Directional, not a quoted figure.
Benchmarked against 21302 companies in Other Technology. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 85% of sector peers (real $). Modeled value above 66% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #289 of 314.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Certified Inc. | Series B | $40.0M | $1.2B | 2.07× |
| Universal Recognition Token, Inc. | Series B | $40.0M | $1.2B | 2.07× |
| Pymetrics, Inc. | Series B | $46.6M | $1.2B | 2.07× |
| Anomali Inc | Series B | $40.0M | $1.2B | 2.07× |
| Docutech Transfer, LLC | Series B | $39.9M | $1.2B | 2.07× |
| Plaid Technologies, Inc. | Series B | $39.8M | $1.2B | 2.06× |
| 360fly, Inc. | Series B | $69.9M | $1.2B | 2.05× |
| LogRhythm, Inc. | Series B | $111.3M | $1.2B | 2.05× |
| Humu, Inc. | Series B | $49.5M | $1.2B | 2.02× |
| GuiaBolso (Cayman), Ltd. | Series B | $58.0M | $1.2B | 2.01× |
| Spin Memory, Inc. | Series B | $38.5M | $1.2B | 2.00× |
| Wavefront, Inc. | Series B | $37.6M | $1.1B | 1.95× |
| APOS - Medical & Sports Technologies Ltd. this company | Series B | $23.1M | $76.1M | 0.13× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series B | $15.3M | 2014-11-24 | $85.2M | $466.8M | 90% |
| Series B | $5.3M | 2015-12-17 | $29.4M | $160.9M | 90% |
| Series B | $2.5M | 2016-06-16 | $13.9M | $76.1M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| David Levy | — | 8 other | 2014-11 |
| Michael Stocker | — | 5 other | 2014-11 |
| John Cox | — | 2 other | 2016-06 |
| Ruth Alon | — | 1 other | 2014-11 |
| Alan J. Milburn | — | — | 2015-12 |
| Alan Milburn | — | — | 2014-11 |
| Amit J. Mor | — | — | 2015-12 |
| Amit Mor | — | — | 2014-11 |
| Avi Elbaz | — | — | 2014-11 |
| Avi J. Elbaz | — | — | 2015-12 |
| David J. Levy | — | — | 2015-12 |
| David Levy Levy | — | — | 2016-06 |
| Donald Almeida | — | — | 2014-11 |
| Donald J. Almeida | — | — | 2015-12 |
| John J. Cox | — | — | 2015-12 |
| Limor Schwartz | — | — | 2014-11 |
| Michael J. Stocker | — | — | 2015-12 |
| Oded Griffel | — | — | 2014-11 |
| Ruth J. Alon | — | — | 2015-12 |
APOS - Medical & Sports Technologies Ltd. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Simulmedia, Inc. | Other Technology | Series B | $86.6M | $894.0M | network1 shared operator · same sector · same stage |
| Sapient Corp | Other Technology | Series B | $25.8M | $73.1M | same sector · same stage |
| Mirics Inc. | Other Technology | Series B | $20.5M | $76.1M | same sector · same stage |
| HALOSAUCER Corp | Other Technology | Series B | $20.0M | $74.0M | same sector · same stage |
| HospitalityMatches.com, Inc. | Other Technology | Series B | $20.0M | $74.0M | same sector · same stage |
| Redworc Technologies LLC | Other Technology | Series B | $20.0M | $74.0M | same sector · same stage |
| Ringorang Worldwide LLC | Other Technology | Series B | $20.0M | $74.0M | same sector · same stage |
| RiskStreet, LLC | Other Technology | Series B | $20.0M | $74.0M | same sector · same stage |
See where APOS - Medical & Sports Technologies Ltd. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at APOS - Medical & Sports Technologies Ltd., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.